Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Unknown × Tea × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Completed 8 Terminated 3 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1

Interventions

Cisplatin 242 Carboplatin 168 Oxaliplatin 161 Capecitabine 157 Docetaxel 156 apatinib 152 Paclitaxel 145 Gemcitabine 136 Radiotherapy 131 Bevacizumab 130 camrelizumab 126 Fluorouracil 125 Cyclophosphamide 114 Irinotecan 109 Etoposide 91 Drug Therapy 91 sintilimab 88 S 1 (combination) 76 Leucovorin 72 anlotinib 71 Doxorubicin 70 pembrolizumab 69 tislelizumab 66 toripalimab 65 Pemetrexed 65 Dexamethasone 62 Rituximab 61 Neoadjuvant Therapy 59 Cetuximab 58 Trastuzumab 57

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡